The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Diversity, classification and evolution of CRISPR-Cas systems
Open accessAbstract
The bacterial and archaeal CRISPR-Cas systems of adaptive immunity show remarkable diversity of protein composition, effector complex structure, genome locus architecture and mechanisms of adaptation, pre-CRISPR (cr)RNA processing and interference. The CRISPR-Cas systems belong to two classes, with multi-subunit effector complexes in Class 1 and single-protein effector modules in Class 2. Concerted genomic and experimental efforts on comprehensive characterization of Class 2 CRISPR-Cas systems led to the identification of two new types and several subtypes. The newly characterized type VI systems are the first among the CRISPR-Cas variants to exclusively target RNA. Unexpectedly, in some of the class 2 systems, the effector protein is additionally responsible for the pre-crRNA processing. Comparative analysis of the effector complexes indicates that Class 2 systems evolved from mobile genetic elements on multiple, independent occasions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The main difference between the classes is that the effector module of Class 1 systems is represented by a complex of several proteins, while in Class 2 it is a single multidomain protein (Cas9, Cas12, or Cas13) [26-28].”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [27]
In the citing paper
“Therefore, organisms possessing CRISPR-Cas systems can identify and degrade foreign DNA.”
From Characterization of Limnospira platensis PCC 9108 R-M and CRISPR-Cas systems (2024) · cites this paper as Koonin et al., 2017
In the citing paper
“CRISPR-Cas (that stand for Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated proteins) is an adaptive immunity system that confers immune memory stored in the form of spacer sequences derived from foreign DNA inserted into the leaderrepeat junction (Garrett et al., 2011; Koonin et al., 2017).”
From Characterization of Limnospira platensis PCC 9108 R-M and CRISPR-Cas systems (2024) · cites this paper as Koonin et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Self-citationGasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
An updated evolutionary classification of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,480
Self-citationC2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336
Self-citationEvolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationCrystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
Self-citationTwo distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
East-Seletsky, A., O’Connell, M. R., Knight, S. C., Burstein, D., Cate, J. H. D., Tjian, R., & Doudna, J. A. (2016) · Nature · doi:10.1038/nature19802 · Cited by 1,236
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,209
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 999
CRISPR delivery systems for organ-specific targeting: Advances and challenges
Du, J., Wu, Q., Liu, C., Wang, N., & Gong, C. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100048 · Cited by 20
Targeted assemblies of cas1 suggest CRISPR-Cas’s response to soil warming
Wu, R., Chai, B., Cole, J. R., Gunturu, S., Guo, X. Y., Tian, R., Gu, J., Zhou, J. Z., & Tiedje, J. M. (2020) · The ISME Journal · doi:10.1038/s41396-020-0635-1 · Cited by 15
Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery
He, J., Biswas, R., Bugde, P., Li, J., Liu, D., & Li, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050894 · Cited by 16
Decrypting the mechanistic basis of CRISPR/Cas9 protein
Panda, G., & Ray, A. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.05.001 · Cited by 17
Structural basis of AcrIF24 as an anti-CRISPR protein and transcriptional suppressor
Mukherjee, I. A., Gabel, C. A., Noinaj, N., Bondy‐Denomy, J., & Chang, L. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01137-w · Cited by 15
Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens
Gao, H., Shang, Z., Chan, S. Y., & Ma, D. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200068 · Cited by 15
Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector
Huo, Y., Zhao, H., Dong, Q., & Jiang, T. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01316-4 · Cited by 15
Kumar, D., & Kirti, P. B. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1275854 · Cited by 16
Mousavi, S. M., Hashemi, S. A., Kalashgrani, M. Y., Rahmanian, V., Riazi, M., Omidifar, N., Althomali, R. H., Rahman, M. M., Chiang, W., & Gholami, A. (2023) · ChemMedChem · doi:10.1002/cmdc.202300359 · Cited by 15
The immune system of prokaryotes: potential applications and implications for gene editing
Liu, S. M., Liu, H., Wang, X., & Shi, L. (2024) · Biotechnology Journal · doi:10.1002/biot.202300352 · Cited by 16
Malesa, R. P., Pierneef, R., Magwedere, K., Mafuna, T., & Matle, I. (2024) · Frontiers in Bacteriology · doi:10.3389/fbrio.2024.1432292 · Cited by 16
Kaur, J., Ananthu Viswanathan, P., & Bari, V. K. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01623-z · Cited by 15
Nickel, L., Ulbricht, A., Alkhnbashi, O. S., Förstner, K. U., Cassidy, L., Weidenbach, K., Backofen, R., & Schmitz, R. A. (2018) · RNA Biology · doi:10.1080/15476286.2018.1514234 · Cited by 15
Yang, D., Wang, Z., Ma, J., Fu, Q., Wu, L., Wang, H., Wang, S., Yan, Y., & Sun, J. (2020) · Viruses · doi:10.3390/v12010090 · Cited by 15
Bourgeois, J., Lazinski, D. W., & Camilli, A. (2020) · mSphere · doi:10.1128/msphere.00813-20 · Cited by 15
Point‐of‐Care Pathogen Detection with CRISPR‐based Programmable Nucleic Acid Binding Proteins
Dhar, B. C., Steimberg, N., & Mazzoleni, G. (2020) · ChemMedChem · doi:10.1002/cmdc.202000782 · Cited by 17
Genome editing technologies: CRISPR, LEAPER, RESTORE, ARCUT, SATI, and RESCUE
Görücü Yılmaz, Ş. (2021) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2020-3070
CRISPR-Associated Primase-Polymerases are implicated in prokaryotic CRISPR-Cas adaptation
Zábrady, K., Zábrady, M., Kolesár, P., Li, A. W. H., & Doherty, A. J. (2021) · Nature Communications · doi:10.1038/s41467-021-23535-9 · Cited by 15
Baghini, S. S., Gardanova, Z. R., Zekiy, A. O., Shomali, N., Tosan, F., & Jarahian, M. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.775309 · Cited by 16
RetractedLi, K., Luo, S., Guan, S., Situ, B., Wu, Y. S., Ou, Z., Tao, M., Zheng, L., & Cai, Z. (2022) · Talanta · doi:10.1016/j.talanta.2022.123531 · Cited by 15
Makarova, K. S., Karamycheva, S. A., Shah, S. A., Vestergaard, G., Garrett, R. A., & Koonin, E. V. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz079 · Cited by 15
Self-citationDirect observation of the formation of a CRISPR–Cas12a R-loop complex at the single-molecule level
Cui, Y., Tang, Y., Liang, M., Ji, Q., Zeng, Y., Chen, H., Lan, J., Jin, P. K., Wang, L., Song, G., et al. (2020) · Chemical Communications · doi:10.1039/c9cc08325a · Cited by 15
Type IV CRISPR associated RNA endonuclease Cas6 - apo form
Jackson, R. N., Warner, E. E., & Olsen, K. J. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6njy/pdb · Cited by 15
Yang, Y., Xu, Z., Soteyome, T., Premarathna, M., Yin, X., & Liu, J. (2025) · Pharmaceuticals · doi:10.3390/ph18111688 · Cited by 17
Mechanism of primer synthesis by Primase-Polymerases
Zábrady, K., Li, A. W. H., & Doherty, A. J. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102652 · Cited by 14
CRISPR/Cas, Multiomics, and RNA Interference in Virus Disease Management
Viswanath, K. K., Hamid, A., Ateka, E., & Pappu, H. R. (2023) · Phytopathology · doi:10.1094/phyto-01-23-0002-v · Cited by 14
Gene editing in common cardiovascular diseases
Lauerer, A.-M., Caravia, X. M., Maier, L. S., Chemello, F., & Lebek, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108720 · Cited by 15
CRISPR-Cas9 system: A potent tool to fight antibiotic resistance in bacteria
Moitra, A., Chakraborty, A., & Dam, B. (2024) · The Microbe · doi:10.1016/j.microb.2024.100184 · Cited by 17
Marnis, H., & Syahputra, K. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110220 · Cited by 16
Bacteriophages of Myxococcus xanthus, a Social Bacterium
Vasse, M., & Wielgoss, S. (2018) · Viruses · doi:10.3390/v10070374 · Cited by 14
Directed evolution studies of a thermophilic Type II-C Cas9
Hand, T. H., Das, A., & Li, H. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.029 · Cited by 12
Martín-Cuadrado, A.-B., Senel, E., Martínez‐García, M., Cifuentes, A., Santos, F., Almansa, C., Moreno‐Paz, M., Blanco, Y., García‐Villadangos, M., del Cura, M. Á. G., et al. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14680 · Cited by 14
Recent advances in CRISPR research
Chen, B., Niu, Y., Wang, H., Wang, K., Yang, H., & Li, W. (2020) · Protein & Cell · doi:10.1007/s13238-020-00704-y · Cited by 15
CRISPR-Cas12a-Assisted Genome Editing in Amycolatopsis mediterranei
Zhou, Y., Liu, X., Wu, J., Zhao, G., & Wang, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00698 · Cited by 14
CRISPR-Cas system, antibiotic resistance and virulence in bacteria: Through a common lens
Roy, S., Naha, S., Rao, A., & Basu, S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.005 · Cited by 14
Characterization of Blf4, an Archaeal Lytic Virus Targeting a Member of the Methanomicrobiales
Weidenbach, K., Wolf, S., Kupczok, A., Kern, T., Fischer, M. A., Reetz, J., Urbańska, N., Künzel, S., Schmitz, R. A., & Rother, M. (2021) · Viruses · doi:10.3390/v13101934 · Cited by 15
Kim, S., Jeong, Y. K., Cho, C. S., Lee, S., Sohn, C. H., Kim, J. H., Jeong, Y., Jo, D. H., Bae, S., & Lee, H. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201825 · Cited by 13
Intracellular signaling in CRISPR-Cas defense
Amitai, G., & Sorek, R. (2017) · Science · doi:10.1126/science.aao2210 · Cited by 14
A CRISPR‐Cas9 tool to explore the genetics of Bacillus subtilis phages
Otte, K. L., Kühne, N. M., Furrer, A. D., Lozada, L. P. B., Lutz, V. T., Schilling, T., & Hertel, R. (2020) · Letters in Applied Microbiology · doi:10.1111/lam.13349 · Cited by 14
Expansion of the CRISPR/Cas Genome-Sculpting Toolbox: Innovations, Applications and Challenges
Batool, A., Malik, F. A., & Andrabi, K. I. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00500-8 · Cited by 14
Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13
Burris, B. J. D., Molina Vargas, A. M., Park, B. J., & O'Connell, M. R. (2022) · Methods · doi:10.1016/j.ymeth.2022.08.007 · Cited by 13
Guo, T., Zheng, F., Zeng, Z., Yang, Y., Li, Q., She, Q., & Han, W. (2019) · RNA Biology · doi:10.1080/15476286.2019.1642725 · Cited by 11
Cheng, Y., Guo, W., Wan, Y., Li, S., Zhou, J., & Wang, J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03865 · Cited by 12
Güven, E., & Azizoğlu, R. O. (2022) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2021.0078 · Cited by 13
Progress of CRISPR-Cas13 Mediated Live-Cell RNA Imaging and Detection of RNA-Protein Interactions
Cao, H., Wang, Y., Zhang, N., Xia, S., Tian, P., Li, L., Du, J., & Du, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.866820 · Cited by 16
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection
Arriaga-Canon, C., Contreras‐Espinosa, L., Rebollar‐Vega, R., Montiel-Manríquez, R., Cedro‐Tanda, A., García-Gordillo, J. A., Álvarez-Gómez, R. M., Jiménez-Trejo, F. J., Hernández, C. C., & Herrera, L. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911058 · Cited by 14
Advances and applications of CRISPR/Cas-mediated interference in Escherichia coli
Lim, X., Zhang, C., & Chen, X. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100123 · Cited by 14
Comparative Probiogenomics Analysis of Limosilactobacillus fermentum 3872
Ullah, M., Rizwan, M., Han, J., Raza, A., Chen, Y.-Z., Yan, M., Ma, Y., Ni, Z., Olawale, O. A., & Chen, H. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10286-4 · Cited by 13
CRISPR/CasRx-mediated resistance to Soybean mosaic virus in soybean
Gao, L., Xie, L., Xiao, Y., Cheng, X., Pu, R., Zhang, Z., Liu, Y., Gao, S., Zhang, Z., Qu, H., et al. (2024) · The Crop Journal · doi:10.1016/j.cj.2024.07.007 · Cited by 13
Du, Q., Wei, Y., Zhang, L., Ren, D., Gao, J., Dong, X., Bai, L.-P., & Li, J. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02492-0 · Cited by 13
CRISPR: New promising biotechnological tool in wastewater treatment
Bhanu, L. S. M., Kataki, S., & Chatterjee, S. (2024) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2024.107066 · Cited by 15
PAM-adjacent DNA flexibility tunes CRISPR-Cas12a off-target binding
Allen, A., Cooper, B. H., Singh, J. K., Rohs, R., & Qin, P. Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-87565-9 · Cited by 17
Zou, H., Huang, X., Xiao, W., He, H., Liu, S., & Zeng, H. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128107 · Cited by 13
Blankenship, H. M., Mosci, R. E., Phan, Q., Fontana, J., Rudrik, J. T., & Manning, S. D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00529 · Cited by 13
Siva, N., Gupta, S., Gupta, A., Shukla, J. N., Malik, B., & Shukla, N. (2021) · 3 Biotech · doi:10.1007/s13205-021-02680-4 · Cited by 14
Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review
Bui, L. M., Phùng, H. T. T., Thi, T.-T. H., Singh, V., Maurya, R., Khambhati, K., Wu, C., Uddin, M. J., Trung, D. M., & Chu, D. (2021) · Bioengineered · doi:10.1080/21655979.2021.1987821 · Cited by 16
Cigan, A. M., & Knap, P. W. (2022) · CABI Agriculture and Bioscience · doi:10.1186/s43170-022-00107-5 · Cited by 15
Phage Against the Machine: Discovery and Mechanism of Type V Anti-CRISPRs
Marino, N. D. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168054 · Cited by 13
Applications of CRISPR technology in cellular immunotherapy
Zhou, X., Renauer, P. A., Zhou, L., Fang, S., & Chen, S. (2023) · Immunological Reviews · doi:10.1111/imr.13241 · Cited by 14
Fluorescence-based methods for measuring target interference by CRISPR–Cas systems
Phan, P. T., Schelling, M. A., Xue, C., & Sashital, D. G. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.027 · Cited by 13
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
Miri, S. M., Tafsiri, E., Cho, W. C. S., & Ghaemi, A. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01546-8 · Cited by 15
CRISPR/Cas system-based strategies for pathogenic bacteria detection
Zheng, Y., Sun, X., Li, X., Lei, J., & Song, E. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118497 · Cited by 12
Big things come in small packages: Using nanomaterials for plant genetic engineering
Leal, G. G., dos Santos, Y. B. L., Ito, M. E. Q. S., & de Souza, W. R. (2025) · Plant Nano Biology · doi:10.1016/j.plana.2025.100219 · Cited by 12
Li, H., Tan, Y., & Zhang, D. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.036 · Cited by 12
Application of CRISPR/Cas9-based genome editing in ecotoxicology
Zhao, F., Ding, X., Liu, Z., Yan, X. F., Chen, Y., Jiang, Y., Chen, S., Wang, Y., Kang, T., Xie, C., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122458 · Cited by 13
Zhang, X., Li, H., Zhao, W., Xu, J., Wang, S., & Yu, R. (2023) · Microchimica Acta · doi:10.1007/s00604-023-06038-w · Cited by 12
Type I CRISPR-Cas-mediated microbial gene editing and regulation
Xu, Z., Chen, S., Wu, W., Wen, Y., & Cao, H. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023040 · Cited by 12
CRISPR-based gene editing in plants: Focus on reagents and their delivery tools
Ebrahimi, V., & Hashemi, A. (2024) · Bioimpacts · doi:10.34172/bi.30019 · Cited by 14
Cas1 mediates the interference stage in a phage-encoded CRISPR–Cas system
Zhang, L., Wang, H., Zeng, J., Cao, X., Gao, Z., Liu, Z., Li, F., Wang, J., Zhang, Y., Yang, M., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01659-5 · Cited by 12
Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson’s Disease
Choi, W., Cha, S., & Kim, K. (2024) · Cells · doi:10.3390/cells13141214 · Cited by 15
Chattopadhyay, R., Firdous, Z., & Bari, V. K. (2024) · Physiological and Molecular Plant Pathology · doi:10.1016/j.pmpp.2024.102482 · Cited by 12
Lapee-e, V., Nuanualsuwan, S., Hongtanee, L., & Yakoh, A. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.113055 · Cited by 12
Allemailem, K. S., Rahmani, A. H., Almansour, N. M., Aldakheel, F. M., Albalawi, G., Albalawi, G., & Khan, A. A. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5748 · Cited by 12
Temporal dynamics of collateral RNA cleavage by LbuCas13a in human cells
Bot, J. F., Zhao, Z., Li, M., Kammeron, D., Shang, P., & Geijsen, N. (2026) · Communications Biology · doi:10.1038/s42003-026-09511-3 · Cited by 12
Understanding off-target effects through hybridization kinetics and thermodynamics
Nazipova, N. N., & Shabalina, S. A. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09505-4 · Cited by 11
An overview of currently available molecular Cas-tools for precise genome modification
Kondrateva, E. V., Demchenko, A. G., Лавров, А. В., & Smirnikhina, S. (2020) · Gene · doi:10.1016/j.gene.2020.145225 · Cited by 13
Molina, R., Garcia-Martin, R., Mendez, B. L., Jensen, A. L. G., Ciges-Tomas, J. R., Marchena-Hurtado, J., Stella, S., & Montoya, G. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac923 · Cited by 12
The effects of length and sequence of gRNA on Cas13b and Cas13d activity in vitro and in vivo
Liu, Y., Jing, P., Zhou, Y., Zhang, J., Shi, J., Zhang, M., Yang, H., & Fei, J. (2023) · Biotechnology Journal · doi:10.1002/biot.202300002 · Cited by 12
Yiğider, E., Taşpınar, M. S., & Ağar, G. (2023) · Planta · doi:10.1007/s00425-023-04199-9 · Cited by 14
Genomic investigation of emerging zoonotic pathogen Shewanella xiamenensis
Tung, K., Wang, J.-H., & Tseng, S. (2019) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_69_19 · Cited by 12
How Crisp is CRISPR? CRISPR-Cas-mediated crop improvement with special focus on nutritional traits
Kaul, T., Sony, S. K., Raman, N. M., Eswaran, M., Verma, R., Prakash, A. T., Bharti, J., Motelb, K. F. A., & Kaul, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818581-0.00011-5 · Cited by 12
Investigating the Genomic Background of CRISPR-Cas Genomes for CRISPR-Based Antimicrobials
Shim, H. (2022) · Evolutionary Bioinformatics · doi:10.1177/11769343221103887 · Cited by 12
A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
Porter, S. N., Levine, R. M., & Pruett‐Miller, S. M. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180022 · Cited by 18
Chronic In Vivo CRISPR-Cas Genome Editing: Challenges, Long-Term Safety, and Outlook
Bao, C., Channell, C. I., Tseng, Y.-H., Bailey, J., Sbaiti, N., Demirkol, A., & Tsang, S. H. (2026) · Cells · doi:10.3390/cells15020156 · Cited by 14
Molecular and Computational Strategies to Increase the Efficiency of CRISPR-Based Techniques
Mattiello, L., Rütgers, M., Sua-Rojas, M. F., Tavares, R., Soares, J. S., Begcy, K., & Menossi, M. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.868027 · Cited by 12
Recent progress of molecular diagnosis via CRISPR Cas-based biosensors and bioassays
Nazir, S. (2023) · Talanta Open · doi:10.1016/j.talo.2023.100225 · Cited by 12
Genetically Engineered Plastic Munching Microbes: Recent Advancements and Perspectives
Saini, N., Bharti, D., Singh, S., Banoo, R., Bundela, V., Nain, P., & Sahgal, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-55661-6_8 · Cited by 14
Jin, K., Huang, P., Li, B., Cao, Z., Huang, Z., Zhang, Z., Liu, M., Li, H., Niu, L., Zhang, T., et al. (2024) · Transboundary and Emerging Diseases · doi:10.1155/2024/4118007 · Cited by 11
CRISPR-Cas Systems: A Functional Perspective and Innovations
Navarro, C., Diaz, M. P., Durán, P., Castro, A., Díaz, A., Cano, C., Carbonell, A., Solano-Jimenez, D.-S., Rivera-Porras, D., Contreras-Velásquez, J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083645 · Cited by 16
Scrascia, M., D’Addabbo, P., Roberto, R., Porcelli, F., Oliva, M., Calia, C., Dionisi, A. M., & Pazzani, C. (2019) · Microorganisms · doi:10.3390/microorganisms7090368 · Cited by 11
A Membrane-Associated DHH-DHHA1 Nuclease Degrades Type III CRISPR Second Messenger
Zhao, R., Yang, Y., Zheng, F., Zeng, Z., Feng, W., Jin, X., Wang, J., Yang, K., Liang, Y. X., She, Q., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108133 · Cited by 12
Sequential Genome Editing and Induced Excision of the Transgene in N. tabacum BY2 Cells
Sheva, M., Hanania, U., Ariel, T., Turbovski, A., Rathod, V. K. R., Oz, D., Tekoah, Y., & Shaaltiel, Y. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.607174 · Cited by 11
Insights of CRISPR-Cas systems in stem cells: progress in regenerative medicine
Shanmugam, D. K., Aashabharathi, M., Devi, G. K., Subbaiya, R., & Saravanan, M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06832-w · Cited by 11
Sun, W., Guo, W., Liu, Z., Qiao, S., Wang, Z., Wang, J., Qu, L., Shan, L., Sun, F., Xu, S., et al. (2022) · Lab on a Chip · doi:10.1039/d1lc01055g · Cited by 11
CRISPR-Based Tools for Fighting Rare Diseases
Li, Q., Gao, Y., & Wang, H. (2022) · Life · doi:10.3390/life12121968 · Cited by 11
Du, L., Zhang, D., Luo, Z., & Lin, Z. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad101 · Cited by 10
Wang, Y., Xia, X., Wu, M., Sun, Q., Zhang, W., Qiu, Y., Deng, R., & Luo, A. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c04775 · Cited by 11
trans -Cleavage of the CRISPR-Cas12a-aptamer system for one-step antigen detection
Fan, H., Luo, S., Zhu, Y., Shi, J., Yin, F., & Li, J. (2023) · Chemical Communications · doi:10.1039/d3cc04532c · Cited by 11
CRISPR–Cas10 assisted editing of virulent staphylococcal phages
Bari, S. M. N., & Hatoum-Aslan, A. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.023 · Cited by 11
Biotechnological Approaches for the Resistance to Citrus Diseases
Dutt, M., El-Mohtar, C. A., & Wang, N. (2020) · Compendium of plant genomes · doi:10.1007/978-3-030-15308-3_14 · Cited by 11
Metadata
- Authors
- Koonin, E. V., Makarova, K. S., & Zhang, F.
- Affiliations
- United States National Library of Medicine (US)
- Broad Institute (US)
- Corresponding author
- Koonin, Eugene V
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 37
- Pages
- 67-78
- ISSN
- 1369-5274 (ISSN-L)
- PMC
- PMC5776717
- OpenAlex
- W2623277795
- Cited by
- 1,423
- References
- 73
- Citations by year
- 2026: 70 · 2025: 139 · 2024: 157 · 2023: 136 · 2022: 184 · 2021: 191 · 2020: 178 · 2019: 206 · 2018: 127 · 2017: 33
- FWCI
- 13.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institutes of Health
- U.S. National Library of Medicine (Z01LM000073)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR-Cas, adaptive immunity, mobile genetic elements, CRISPR adaptation, comparative genomics
- MeSH terms
- Archaea, Bacteria, Genetic Variation, Evolution, Molecular, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review